Source · Select Committees · Health and Social Care Committee

Tenth Report - Prevention in health and social care: vaccination

Health and Social Care Committee HC 1764 Published 27 July 2023
Report Status
Government responded
Conclusions & Recommendations
10 items (6 recs)
Government Response
AI assessment · 10 of 10 classified
Accepted 6
Accepted in Part 2
Deferred 2
Filter by: Clear

Recommendations

2 results
10 Accepted in Part

Prepare regulatory and delivery systems for future personalised preventative healthcare innovations.

Recommendation
Exciting innovations are on the horizon and have the potential to transform preventative healthcare. While the timeframe for such innovations, like a personalised cancer vaccine, is unknown, future planning must be done on the assumption that personalised therapeutics will become … Read more
Government Response Summary
The government outlines existing effective regulatory and delivery processes for new medicines and states it monitors partner organizations. It highlights £10 million funding allocated to MHRA to accelerate bringing innovative medicines to UK patients, aligning with the goal of faster access.
Department of Health and Social Care
View Details →
11 Accepted in Part

Require DHSC and NHS England to submit plan for regulatory readiness and resourcing.

Recommendation
The Department of Health and Social Care and NHS England must lay before Parliament a plan for how they intend to ensure all relevant regulatory and delivery systems are ready to assess and deliver these new innovations to patients. As … Read more
Government Response Summary
The government describes existing regulatory processes and monitoring for new medicines, detailing how it supports JCVI's modelling capabilities and allocates £10 million over two years to MHRA for accelerating innovative medicine delivery, but does not commit to laying a formal plan before Parliament as requested.
Department of Health and Social Care
View Details →